Skip to content

Role of Ashtamangal Ghrita -Oral & Nasya in Cerebral Palsy

A Clinical Study to Evaluate the Efficacy of Ashtamangal Ghrita - Oral and Nasya in the Management of Cerebral Palsy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014415
Enrollment
30
Registered
2018-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- children with developmental disabilities of both physical and mental

Interventions

Intervention1: ashtamangal ghrita orally: Group A - oral dose of ashtamangal ghrita 1 ml/kg body weight in two divided doses for 3 months shastikashali pinda sweda will be done for 20 days daily afte

Sponsors

STATE AYURVEDIC COLLEGE AND HOSPITAL LUCKNOW
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: children with cerebral palsy aged 1 year to 10 years of either sex children with developmental disabilities of both physical and mental already diagnosed cases of cerebral palsy

Exclusion criteria

Exclusion criteria: children below 1 year and above 10 years of age children of cerebral palsy with major congenital disorder and other disease status juvenile diabetes mellitus acute infections children with any progressive neurological anomalies children suffering from any muscular dystrophy children with severe systemic illness

Design outcomes

Primary

MeasureTime frame
Improvement in overall sensory and motor dysfunction using CDC grading scale , modified barthel score and modified ashworth scaleTimepoint: 3 MONTHS

Secondary

MeasureTime frame
analysis of effect of ashtamangal ghrita when administered nasally and orally in children with cerebral palsyTimepoint: 3 months

Countries

India

Contacts

Public ContactDR KALPANA PATNI

STATE AYURVEDIC COLLEGE AND HOSPITAL LUCKNOW

kalpana.patni@gmail.com8318644261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026